Search Results1-6 of  6

  • OKUYAMA Kotoba ID: 9000001710100

    Clinical Development Institute, Banyu Pharmaceutical Co., Ltd. (2005 from CiNii)

    Articles in CiNii:1

    • Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study (2005)
  • OKUYAMA Kotoba ID: 9000018779417

    Banyu Pharmaceutical Co., LTD. (2010 from CiNii)

    Articles in CiNii:1

    • Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus (2010)
  • Okuyama Kotoba ID: 9000257804176

    Banyu Pharmaceutical Co., LTD., Tokyo, Japan (2010 from CiNii)

    Articles in CiNii:1

    • Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus (2010)
  • Okuyama Kotoba ID: 9000390886789

    Department of Medical Affairs, MSD K.K. (2018 from CiNii)

    Articles in CiNii:1

    • Low-Density Lipoprotein Cholesterol Goal Attainment Rates by Initial Statin Monotherapy Among Patients With Dyslipidemia and High Cardiovascular Risk in Japan ― A Retrospective Database Analysis ― (2018)
  • Okuyama Kotoba ID: 9000398148516

    Medical Affairs, MSD K.K. (2018 from CiNii)

    Articles in CiNii:1

    • A positive rate for HCV antibody in subjects who never were measured the HCV antibody in regular health checkups (2018)
  • Okuyama Kotoba ID: 9000405641939

    Medical Affairs, MSD K.K. (2019 from CiNii)

    Articles in CiNii:1

    • Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients with Type 2 Diabetes (2019)
Page Top